Literature DB >> 8096565

Transmural myocardial infarction with sumatriptan.

J P Ottervanger1, H J Paalman, G L Boxma, B H Stricker.   

Abstract

For sumatriptan, tightness in the chest caused by an unknown mechanism has been reported in 3-5% of users. We describe a 47-year-old woman with an acute myocardial infarction after administration of sumatriptan 6 mg subcutaneously for cluster headache. The patient had no history of underlying ischaemic heart disease or Prinzmetal's angina. She recovered without complications.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8096565     DOI： 10.1016/0140-6736(93)93064-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  18 in total

1.  Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries.

Authors:  Christopher M H Newman; Ian Starkey; Nigel Buller; Ricardo Seabra-Gomes; Simon Kirby; Jayasena Hettiarachchi; David Cumberland; William S Hillis
Journal:  Eur J Clin Pharmacol       Date:  2005-09-08       Impact factor: 2.953

2.  A case of myocardial infarction with sumatriptan use.

Authors:  E Erbilen; H Ozhan; R Akdemir; M Yazici
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

3.  Postmarketing study of cardiovascular adverse reactions associated with sumatriptan.

Authors:  J P Ottervanger; T B van Witsen; H A Valkenburg; B H Stricker
Journal:  BMJ       Date:  1993-11-06

Review 4.  Headache.

Authors:  J M Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

5.  Adverse reactions attributed to sumatriptan. A postmarketing study in general practice.

Authors:  J P Ottervanger; T B van Witsen; H A Valkenburg; D E Grobbee; B H Stricker
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.

Authors:  G W Rebeck; K I Maynard; B T Hyman; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro.

Authors:  A Ferro; J Longmore; R G Hill; M J Brown
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

8.  The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.

Authors:  P Gupta; D Brown; P Butler; P Ellis; K L Grayson; G C Land; J E Macor; S F Robson; M J Wythes; N B Shepperson
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

Review 9.  Sumatriptan. An updated review of its use in migraine.

Authors:  C M Perry; A Markham
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

10.  Triptans and troponin: a case report.

Authors:  Claudia R Weder; Markus Schneemann
Journal:  Orphanet J Rare Dis       Date:  2009-06-18       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.